NanJing Pharmaceutical Co Ltd (600713) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.119x

Based on the latest financial reports, NanJing Pharmaceutical Co Ltd (600713) has a cash flow conversion efficiency ratio of -0.119x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-942.93 Million ≈ $-137.98 Million USD) by net assets (CN¥7.95 Billion ≈ $1.16 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600713 equity to assets ratio to measure how much of total assets are equity-financed.

NanJing Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how NanJing Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of NanJing Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.

NanJing Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NanJing Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hangzhou Zhongtai Cryogenic Technology Corp SHE:300435	0.067x
SDI Corp TW:2351	0.077x
CAP S.A SN:CAP	0.038x
Yunnan Hongxiang Yixintang SHE:002727	0.069x
Sellas Life Sciences Group Inc NASDAQ:SLS	-0.069x
Sumavision Technologies SHE:300079	0.016x
Beijing Watertek Information Technology Co Ltd SHE:300324	0.004x
Beijing Haitian Ruisheng Science Technology Ltd SHG:688787	0.019x

Annual Cash Flow Conversion Efficiency for NanJing Pharmaceutical Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of NanJing Pharmaceutical Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see market value of NanJing Pharmaceutical Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥7.79 Billion ≈ $1.14 Billion	CN¥2.14 Billion ≈ $312.53 Million	0.274x	+4.36%
2023-12-31	CN¥7.25 Billion ≈ $1.06 Billion	CN¥1.91 Billion ≈ $278.97 Million	0.263x	+357.83%
2022-12-31	CN¥6.69 Billion ≈ $979.67 Million	CN¥-682.31 Million ≈ $-99.84 Million	-0.102x	-176.71%
2021-12-31	CN¥5.23 Billion ≈ $765.86 Million	CN¥695.33 Million ≈ $101.75 Million	0.133x	+155.57%
2020-12-31	CN¥4.82 Billion ≈ $705.34 Million	CN¥-1.15 Billion ≈ $-168.64 Million	-0.239x	-207.64%
2019-12-31	CN¥4.52 Billion ≈ $661.42 Million	CN¥1.00 Billion ≈ $146.91 Million	0.222x	+348.76%
2018-12-31	CN¥4.11 Billion ≈ $601.30 Million	CN¥-366.90 Million ≈ $-53.69 Million	-0.089x	-188.92%
2017-12-31	CN¥3.19 Billion ≈ $466.29 Million	CN¥319.99 Million ≈ $46.82 Million	0.100x	+227.96%
2016-12-31	CN¥3.07 Billion ≈ $449.14 Million	CN¥-240.88 Million ≈ $-35.25 Million	-0.078x	+31.12%
2015-12-31	CN¥2.69 Billion ≈ $393.13 Million	CN¥-306.08 Million ≈ $-44.79 Million	-0.114x	+18.57%
2014-12-31	CN¥2.44 Billion ≈ $356.66 Million	CN¥-341.01 Million ≈ $-49.90 Million	-0.140x	+49.13%
2013-12-31	CN¥1.29 Billion ≈ $188.48 Million	CN¥-354.27 Million ≈ $-51.84 Million	-0.275x	-314.86%
2012-12-31	CN¥1.31 Billion ≈ $192.23 Million	CN¥168.17 Million ≈ $24.61 Million	0.128x	+125.10%
2011-12-31	CN¥1.36 Billion ≈ $198.74 Million	CN¥-692.53 Million ≈ $-101.34 Million	-0.510x	-641.23%
2010-12-31	CN¥1.26 Billion ≈ $184.95 Million	CN¥119.08 Million ≈ $17.42 Million	0.094x	+247.07%
2009-12-31	CN¥744.78 Million ≈ $108.98 Million	CN¥20.22 Million ≈ $2.96 Million	0.027x	+283.11%
2008-12-31	CN¥610.69 Million ≈ $89.36 Million	CN¥4.33 Million ≈ $633.18K	0.007x	-93.87%
2007-12-31	CN¥700.93 Million ≈ $102.57 Million	CN¥81.08 Million ≈ $11.86 Million	0.116x	-53.82%
2006-12-31	CN¥643.97 Million ≈ $94.23 Million	CN¥161.31 Million ≈ $23.61 Million	0.250x	-2.12%
2005-12-31	CN¥646.94 Million ≈ $94.67 Million	CN¥165.57 Million ≈ $24.23 Million	0.256x	+866.48%
2004-12-31	CN¥614.14 Million ≈ $89.87 Million	CN¥16.26 Million ≈ $2.38 Million	0.026x	-15.90%
2003-12-31	CN¥611.84 Million ≈ $89.53 Million	CN¥19.27 Million ≈ $2.82 Million	0.031x	-76.86%
2002-12-31	CN¥505.29 Million ≈ $73.94 Million	CN¥68.75 Million ≈ $10.06 Million	0.136x	+1628.15%
2001-12-31	CN¥472.04 Million ≈ $69.07 Million	CN¥-4.20 Million ≈ $-615.03K	-0.009x	-104.94%
2000-12-31	CN¥486.93 Million ≈ $71.25 Million	CN¥87.68 Million ≈ $12.83 Million	0.180x	+58.29%
1999-12-31	CN¥444.61 Million ≈ $65.06 Million	CN¥50.58 Million ≈ $7.40 Million	0.114x	-37.30%
1998-12-31	CN¥426.92 Million ≈ $62.47 Million	CN¥77.45 Million ≈ $11.33 Million	0.181x	--

About NanJing Pharmaceutical Co Ltd

SHG:600713 China Drug Manufacturers - General

Market Cap

$969.18 Million

CN¥6.62 Billion CNY

Market Cap Rank

#9047 Global

#2220 in China

Share Price

CN¥5.06

Change (1 day)

-0.98%

52-Week Range

CN¥4.84 - CN¥6.40

All Time High

CN¥10.55